Jordan Sloshower, MD, MSc
Psychiatrist
New Haven CT
Dr Sloshower has spent the past decade researching and studying the therapeutic applications of psychedelic medicines (e.g. psilocybin, ketamine, MDMA, and ayahuasca) and how these novel treatments can be integrated with psychotherapy and other healing modalities to promote holistic healing. Dr Sloshower understands these medicines as acting on multiple levels of being, thereby possessing the potential for deep healing of root causes of distress and illness. Rather than suppressing symptoms, he seeks to facilitate clients’ own healing processes by utilizing these medicines in the context of psychotherapy and integrating such ‘medication-assisted therapies’ into a broader approach to wellness and mental health. This may include elements such as diet, exercise, herbal medicines, supplements, somatic therapies, nature therapy, and psychosocial interventions. As a psychotherapist, Dr Sloshower blends elements of psychodynamic, acceptance and commitment, mindfulness-based, somatic, and cognitive-behavioral therapies.
Jordan Sloshower, MD, MSc is a board-certified psychiatrist, researcher, and educator specializing in integrative approaches to mental health and psychedelic-assisted therapies. Dr Sloshower completed his medical and psychiatric training at Yale University, where he co-founded the Yale Psychedelic Science Group and served as an investigator and therapist in several clinical trials of psilocybin-assisted therapy for major depression. He is currently co-director of West Rock Wellness, PLLC in New Haven, CT and a clinical instructor in the Yale Department of Psychiatry.
Dr Sloshower and his colleagues developed The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame). Dr Sloshower received further training in psilocybin therapy from the Usona Institute, where he currently serves as a trainer. He has also been trained by MAPS in MDMA-assisted psychotherapy for PTSD and is a clinical investigator in MAPS’ Expanded Access Program at Behavioral Wellness Clinic in Tolland, CT. Dr Sloshower has experience treating patients with ketamine in both hospital and clinic settings. His approach to ketamine treatment is informed by his other work with psychedelic therapy, and involves harnessing the power of altered states of consciousness to facilitate therapeutic work when combined with psychotherapy (“ketamine-assisted psychotherapy” or KAP).
Reflecting his commitment to ethical stewardship of psychedelic medicines, Dr Sloshower was recently elected to the Board of Directors of the American Psychedelic Practitioners Association and serves as a member of Chacruna Institute’s Council for the Protection of Sacred Plants. His interdisciplinary perspective is informed by prior training in medical anthropology and global health, and deep interests in ceremonial uses of plant medicines, Buddhist philosophy, and integrative approaches to wellness.